Cosentyx (secukinumab) is a prescription drug used to treat multiple conditions, including plaque psoriasis in adults and children ages 6 years and older. Cosentyx is not available as a generic or ...

Cosentyx (secukinumab) is a prescription drug that’s used to treat conditions such as plaque psoriasis and psoriatic arthritis. Cosentyx is given as an injection under the skin or as an IV infusion.

Cosentyx (secukinumab) is a brand-name drug that’s prescribed for certain conditions, including plaque psoriasis and psoriatic arthritis. This article covers topics such as side effects, dosage, and ...

solution in a single-use Sensoready pen solution in a single-use UnoReady pen solution in a single-use prefilled syringe Cosentyx also comes as a solution in a single-use vial that’s given as an ...

The Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) injections for treating various inflammatory conditions in adults and, in some cases, children. Cosentyx may treat moderate ...

Credit: Novartis The IV formulation is supplied as a 125mg/5mL solution in a single-dose vial and requires dilution prior to administration. The Food and Drug Administration (FDA) has approved an ...

The approval was based on data from the phase 3 SUNSHINE and SUNRISE trials, which included 1084 adults with moderate to severe HS. Results showed a significantly greater proportion of patients ...

Approval was supported by adult HS and psoriasis clinical trials, pharmacokinetic modeling, and data from established pediatric indications. The Food and Drug Administration (FDA) has approved ...

Cosentyx, an autoimmune disease therapy that cost the healthcare industry $7.7 billion in 2024, will be offered at a 55% discount beginning in November. The drug’s manufacturer, Novartis, said Sept.